Gemtavis

Product TA

Antineoplastic

Active Ingredient

Gemcitabine

Route Of Administration

IV

Product type

Specialty


Product Details

Specialty

Oncology

Strength

1000 mg

Product Form

Vial

Registration Number

DKI1729200780B1

Consumer Information Leaflet


Product Details

Specialty

Oncology

Strength

200 mg

Product Form

Vial

Registration Number

DKI1729200780A1

Consumer Information Leaflet


Additional products

Oncotaxel

Product TA

Antineoplastic

Active Ingredient

Docetaxel

Route Of Administration

IV

Product type

Specialty
View Product

Lezra

Product TA

Antineoplastic

Active Ingredient

Letrozole

Route Of Administration

Oral

Product type

Specialty
View Product

Page Last Updated: 30 August 2021